These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 19608030)

  • 1. ANKRD1, the gene encoding cardiac ankyrin repeat protein, is a novel dilated cardiomyopathy gene.
    Moulik M; Vatta M; Witt SH; Arola AM; Murphy RT; McKenna WJ; Boriek AM; Oka K; Labeit S; Bowles NE; Arimura T; Kimura A; Towbin JA
    J Am Coll Cardiol; 2009 Jul; 54(4):325-33. PubMed ID: 19608030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mutations in the sarcomeric protein myopalladin in patients with dilated cardiomyopathy.
    Meyer T; Ruppert V; Ackermann S; Richter A; Perrot A; Sperling SR; Posch MG; Maisch B; Pankuweit S;
    Eur J Hum Genet; 2013 Mar; 21(3):294-300. PubMed ID: 22892539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the ANKRD1 gene encoding CARP are responsible for human dilated cardiomyopathy.
    Duboscq-Bidot L; Charron P; Ruppert V; Fauchier L; Richter A; Tavazzi L; Arbustini E; Wichter T; Maisch B; Komajda M; Isnard R; Villard E;
    Eur Heart J; 2009 Sep; 30(17):2128-36. PubMed ID: 19525294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac ankyrin repeat protein gene (ANKRD1) mutations in hypertrophic cardiomyopathy.
    Arimura T; Bos JM; Sato A; Kubo T; Okamoto H; Nishi H; Harada H; Koga Y; Moulik M; Doi YL; Towbin JA; Ackerman MJ; Kimura A
    J Am Coll Cardiol; 2009 Jul; 54(4):334-42. PubMed ID: 19608031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel role for cardiac ankyrin repeat protein Ankrd1/CARP as a co-activator of the p53 tumor suppressor protein.
    Kojic S; Nestorovic A; Rakicevic L; Belgrano A; Stankovic M; Divac A; Faulkner G
    Arch Biochem Biophys; 2010 Oct; 502(1):60-7. PubMed ID: 20599664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis for clinical heterogeneity in inherited cardiomyopathies due to myopalladin mutations.
    Purevjav E; Arimura T; Augustin S; Huby AC; Takagi K; Nunoda S; Kearney DL; Taylor MD; Terasaki F; Bos JM; Ommen SR; Shibata H; Takahashi M; Itoh-Satoh M; McKenna WJ; Murphy RT; Labeit S; Yamanaka Y; Machida N; Park JE; Alexander PM; Weintraub RG; Kitaura Y; Ackerman MJ; Kimura A; Towbin JA
    Hum Mol Genet; 2012 May; 21(9):2039-53. PubMed ID: 22286171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted inhibition of ANKRD1 disrupts sarcomeric ERK-GATA4 signal transduction and abrogates phenylephrine-induced cardiomyocyte hypertrophy.
    Zhong L; Chiusa M; Cadar AG; Lin A; Samaras S; Davidson JM; Lim CC
    Cardiovasc Res; 2015 May; 106(2):261-71. PubMed ID: 25770146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The enigmatic role of the ankyrin repeat domain 1 gene in heart development and disease.
    Mikhailov AT; Torrado M
    Int J Dev Biol; 2008; 52(7):811-21. PubMed ID: 18956313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial overexpression of ANKRD1 causes sinus venosus defects and progressive diastolic dysfunction.
    Piroddi N; Pesce P; Scellini B; Manzini S; Ganzetti GS; Badi I; Menegollo M; Cora V; Tiso S; Cinquetti R; Monti L; Chiesa G; Bleyl SB; Busnelli M; Dellera F; Bruno D; Caicci F; Grimaldi A; Taramelli R; Manni L; Sacerdoti D; Tesi C; Poggesi C; Ausoni S; Acquati F; Campione M
    Cardiovasc Res; 2020 Jul; 116(8):1458-1472. PubMed ID: 31688894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of ankyrin repeat domain 1 enhances cardiomyocyte apoptosis by promoting p53 activation and mitochondrial dysfunction in rodents.
    Shen L; Chen C; Wei X; Li X; Luo G; Zhang J; Bin J; Huang X; Cao S; Li G; Liao Y
    Clin Sci (Lond); 2015 May; 128(10):665-78. PubMed ID: 25511237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analysis of four and half LIM protein-2 in dilated cardiomyopathy.
    Arimura T; Hayashi T; Matsumoto Y; Shibata H; Hiroi S; Nakamura T; Inagaki N; Hinohara K; Takahashi M; Manatsu SI; Sasaoka T; Izumi T; Bonne G; Schwartz K; Kimura A
    Biochem Biophys Res Commun; 2007 May; 357(1):162-7. PubMed ID: 17416352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ankyrin repeat domain 1: A novel gene for cardiac septal defects.
    Yang Y; Xia Y; Wu Y; Huang S; Teng Y; Liu X; Li P; Chen J; Zhuang J
    J Gene Med; 2019 Apr; 21(4):e3070. PubMed ID: 30659708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of ANKRD1 mutations associated with hypertrophic cardiomyopathy on contraction parameters of engineered heart tissue.
    Crocini C; Arimura T; Reischmann S; Eder A; Braren I; Hansen A; Eschenhagen T; Kimura A; Carrier L
    Basic Res Cardiol; 2013 May; 108(3):349. PubMed ID: 23572067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy.
    Brauch KM; Karst ML; Herron KJ; de Andrade M; Pellikka PA; Rodeheffer RJ; Michels VV; Olson TM
    J Am Coll Cardiol; 2009 Sep; 54(10):930-41. PubMed ID: 19712804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of a GATA4/Ankrd1 signaling axis in cardiomyocytes leads to sarcomere disarray: implications for anthracycline cardiomyopathy.
    Chen B; Zhong L; Roush SF; Pentassuglia L; Peng X; Samaras S; Davidson JM; Sawyer DB; Lim CC
    PLoS One; 2012; 7(4):e35743. PubMed ID: 22532871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERK5 induces ankrd1 for catecholamine biosynthesis and homeostasis in adrenal medullary cells.
    Obara Y; Nagasawa R; Nemoto W; Pellegrino MJ; Takahashi M; Habecker BA; Stork PJS; Ichiyanagi O; Ito H; Tomita Y; Ishii K; Nakahata N
    Cell Signal; 2016 Mar; 28(3):177-189. PubMed ID: 26739108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and functional characterization of cardiac troponin I as a novel disease gene in autosomal dominant dilated cardiomyopathy.
    Carballo S; Robinson P; Otway R; Fatkin D; Jongbloed JD; de Jonge N; Blair E; van Tintelen JP; Redwood C; Watkins H
    Circ Res; 2009 Aug; 105(4):375-82. PubMed ID: 19590045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional deregulation and a missense mutation define ANKRD1 as a candidate gene for total anomalous pulmonary venous return.
    Cinquetti R; Badi I; Campione M; Bortoletto E; Chiesa G; Parolini C; Camesasca C; Russo A; Taramelli R; Acquati F
    Hum Mutat; 2008 Apr; 29(4):468-74. PubMed ID: 18273862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of Ankrd1 in Dilated Cardiomyopathy Correlates with the Heart Failure Progression.
    Bogomolovas J; Brohm K; Čelutkienė J; Balčiūnaitė G; Bironaitė D; Bukelskienė V; Daunoravičus D; Witt CC; Fielitz J; Grabauskienė V; Labeit S
    Biomed Res Int; 2015; 2015():273936. PubMed ID: 25961010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha B-crystallin mutation in dilated cardiomyopathy.
    Inagaki N; Hayashi T; Arimura T; Koga Y; Takahashi M; Shibata H; Teraoka K; Chikamori T; Yamashina A; Kimura A
    Biochem Biophys Res Commun; 2006 Apr; 342(2):379-86. PubMed ID: 16483541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.